BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 30639991)

  • 1. Group cognitive behavioural therapy for Chinese patients with psychotic disorder: A feasibility controlled study.
    Wong AWS; Ting KT; Chen EYH
    Asian J Psychiatr; 2019 Jan; 39():157-164. PubMed ID: 30639991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The U&I study: study protocol for a feasibility randomised controlled trial of a pre-cognitive behavioural therapy digital 'informed choice' intervention to improve attitudes towards uptake and implementation of CBT for psychosis.
    Greenwood K; Alford K; O'Leary I; Peters E; Hardy A; Cavanagh K; Field AP; de Visser R; Fowler D; Davies M; Papamichail A; Garety P
    Trials; 2018 Nov; 19(1):644. PubMed ID: 30458850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive behaviour therapy for psychotic symptoms: a randomized controlled effectiveness trial.
    Kråkvik B; Gråwe RW; Hagen R; Stiles TC
    Behav Cogn Psychother; 2013 Oct; 41(5):511-24. PubMed ID: 23635846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosis.
    Farhall J; Freeman NC; Shawyer F; Trauer T
    Br J Clin Psychol; 2009 Mar; 48(Pt 1):47-62. PubMed ID: 18851771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief Coping Strategy Enhancement for Distressing Voices: an Evaluation in Routine Clinical Practice.
    Hayward M; Edgecumbe R; Jones AM; Berry C; Strauss C
    Behav Cogn Psychother; 2018 Mar; 46(2):226-237. PubMed ID: 28651663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A naturalistic, randomized, controlled trial combining cognitive remediation with cognitive-behavioural therapy after first-episode non-affective psychosis.
    Drake RJ; Day CJ; Picucci R; Warburton J; Larkin W; Husain N; Reeder C; Wykes T; Marshall M
    Psychol Med; 2014 Jul; 44(9):1889-99. PubMed ID: 24172842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guided self-help cognitive-behaviour Intervention for VoicEs (GiVE): Results from a pilot randomised controlled trial in a transdiagnostic sample.
    Hazell CM; Hayward M; Cavanagh K; Jones AM; Strauss C
    Schizophr Res; 2018 May; 195():441-447. PubMed ID: 29033279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between depressive symptoms and cognitive-behavioural therapy receipt within a psychosis sample: a cross-sectional study.
    Mason A; Irving J; Pritchard M; Sanyal J; Colling C; Chandran D; Stewart R
    BMJ Open; 2022 May; 12(5):e051873. PubMed ID: 35537795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the minimal dose of cognitive behavior therapy for psychosis? An approximation using repeated assessments over 45 sessions.
    Lincoln TM; Jung E; Wiesjahn M; Schlier B
    Eur Psychiatry; 2016 Oct; 38():31-39. PubMed ID: 27642702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Group cognitive behavioural therapy for psychosis in the Asian context: a review of the recent studies.
    Wong JPS; Ting KT; Wong AWS
    Int Rev Psychiatry; 2019; 31(5-6):460-470. PubMed ID: 31340692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensorimotor gating and clinical outcome following cognitive behaviour therapy for psychosis.
    Kumari V; Premkumar P; Fannon D; Aasen I; Raghuvanshi S; Anilkumar AP; Antonova E; Peters ER; Kuipers E
    Schizophr Res; 2012 Feb; 134(2-3):232-8. PubMed ID: 22138048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group CBT for psychosis: a longitudinal, controlled trial with inpatients.
    Owen M; Sellwood W; Kan S; Murray J; Sarsam M
    Behav Res Ther; 2015 Feb; 65():76-85. PubMed ID: 25577190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using fMRI and machine learning to predict symptom improvement following cognitive behavioural therapy for psychosis.
    Tolmeijer E; Kumari V; Peters E; Williams SCR; Mason L
    Neuroimage Clin; 2018; 20():1053-1061. PubMed ID: 30343250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing access to CBT for psychosis patients: a feasibility, randomised controlled trial evaluating brief, targeted CBT for distressing voices delivered by assistant psychologists (GiVE2).
    Hayward M; Berry C; Cameron B; Arnold K; Berry K; Bremner S; Cavanagh K; Fowler D; Gage H; Greenwood K; Hazell C; Jones AM; Robertson S; Strauss C
    Trials; 2020 Apr; 21(1):302. PubMed ID: 32238176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the delivery of cognitive behavioural therapy for psychosis (CBTp) using a cross-sectional sample from electronic health records and open-text information in a large UK-based mental health case register.
    Colling C; Evans L; Broadbent M; Chandran D; Craig TJ; Kolliakou A; Stewart R; Garety PA
    BMJ Open; 2017 Jul; 7(7):e015297. PubMed ID: 28716789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cognitive-behavioural therapy in early psychosis: an open study in a clinical setting].
    Marois MJ; Gingras N; Provencher MD; Mérette C; Emond C; Bourbeau J; Jomphe V; Roy MA
    Can J Psychiatry; 2011 Jan; 56(1):51-61. PubMed ID: 21324243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual reality cognitive-behavioural therapy versus cognitive-behavioural therapy for paranoid delusions: a study protocol for a single-blind multi-Centre randomised controlled superiority trial.
    Berkhof M; van der Stouwe ECD; Lestestuiver B; Van't Hag E; van Grunsven R; de Jager J; Kooijmans E; Zandee CER; Staring ABP; Pot-Kolder RMCA; Vos M; Veling W
    BMC Psychiatry; 2021 Oct; 21(1):496. PubMed ID: 34635063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of resistance to voices on depression].
    Monestès JL; Vavasseur-Desperriers J; Villatte M; Denizot L; Loas G; Rusinek S
    Encephale; 2015 Feb; 41(1):25-31. PubMed ID: 24815790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive Behavior Therapy for psychosis based Guided Self-help (CBTp-GSH) delivered by frontline mental health professionals: Results of a feasibility study.
    Naeem F; Johal R; McKenna C; Rathod S; Ayub M; Lecomte T; Husain N; Kingdon D; Farooq S
    Schizophr Res; 2016 May; 173(1-2):69-74. PubMed ID: 26971071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary volume reduction in schizophrenia following cognitive behavioural therapy.
    Premkumar P; Bream D; Sapara A; Fannon D; Anilkumar AP; Kuipers E; Kumari V
    Schizophr Res; 2018 Feb; 192():416-422. PubMed ID: 28434719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.